Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,277 | -$28,633 | -$29,687 | -$21,968 |
| Dep. & Amort. | $811 | $144 | $136 | $137 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9,213 | $3,296 | $3,204 | $3,315 |
| Change in WC | $15,645 | $1,154 | -$2,210 | $3,348 |
| Other Non-Cash | -$367 | $72 | $121 | $138 |
| Operating Cash Flow | -$7,975 | -$23,967 | -$28,436 | -$15,030 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$373 | -$196 | -$226 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$53,900 | -$49,182 | $0 | $0 |
| Inv. Sales/Matur. | $18,000 | $3,150 | $0 | $9,600 |
| Other Inv. Act. | -$15,000 | $0 | $0 | $0 |
| Investing Cash Flow | -$51,273 | -$46,228 | -$226 | $9,600 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$104,639 | $90,872 | $11,635 | $2,132 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $905 | $114,694 | $11,635 | $2,150 |
| Financing Cash Flow | $905 | $114,694 | $11,635 | $2,150 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$58,343 | $44,499 | -$17,027 | -$3,280 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102,382 | $57,883 | $74,910 | $78,190 |
| End Cash | $44,039 | $102,382 | $57,883 | $74,910 |
| Free Cash Flow | -$8,348 | -$24,163 | -$28,662 | -$15,030 |